AbbVie

RD oil pipeline

Biotech

Genmab discards ADC from $1.8B ProfoundBio buy

The discarded candidate, dubbed GEN1107, is a PTK7-targeted ADC that was being studied in a phase 1/2 solid tumor trial.

Gabrielle Masson Sep 16, 2025 10:33am

Brain and money connected by a thread on a white background

AbbVie inks $1.2B deal to buy Gilgamesh's psychedelic program

Aug 25, 2025 9:42am

amyloid plaque alzheimers brain

Denali Alzheimer's antibody clears plaques without ARIA in mice

Aug 7, 2025 2:00pm

acquisition merger arrows

AbbVie ends development of IL-1 asset in ulcerative colitis

Jul 31, 2025 12:32pm

Fierce Pharma

AbbVie will continue to pursue external innovation for long-term

Jul 31, 2025 11:44am

Question

AbbVie in talks over $1B Gilgamesh buyout: report

Jul 31, 2025 7:48am